In this issue:
Lung function trajectories and associations with early-life factors
COPD in China
Trial of e-cigarettes, incentives and drugs for smoking cessation
Natural history of COPD exacerbations in general practice
Health services burden of over- and undiagnosed COPD
COPD exacerbations and cardiac events
β-blockers underused in COPD with acute coronary syndrome
LABA/ICS vs. LAMA as initial COPD treatment targeted by eosinophils
Theophylline as adjunct to ICSs, and COPD exacerbations
Worsening breathlessness as a harbinger of death
Download PDF